PHARMACEUTICAL COMPOSITIONS COMPRISING ALPELISIB
The present invention relates to dispersible tablets comprising the compound (S)-Pyrrolidine- 1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin- 4-yl]-thiazol- 2-yl}-amide) or a pharmaceutically acceptable salt thereof. La presente invención se refiere a co...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng ; spa |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The present invention relates to dispersible tablets comprising the compound (S)-Pyrrolidine- 1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin- 4-yl]-thiazol- 2-yl}-amide) or a pharmaceutically acceptable salt thereof.
La presente invención se refiere a comprimidos dispersables que comprenden el (los) compuesto (s) 2-amida 1-({4-metil-5-[2-(2,2,2- trifluoro-1,1-dimetil-etil)-piridin-4-il]-tiazol-2-il}-amida) del ácido (s) pirrolidina-1,2-dicarboxílico o una sal farmacéuticamente aceptable del mismo. |
---|